ReviewJournal of clinical medicine2020

CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis.

Alice Laroni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.